Impact of population-based disease management services (encompassing population analytics and telephone health coaching) on cost and hospitalisation for privately insured Australians with selected chronic conditions

Not Applicable

Completed

• Conditions: Hospital, medical and prostheses costs borne by private insurers.; Public Health - Health promotion/education

• Registration Number: ACTRN12611000580976
• Lead Sponsor: BUPA Health Dialog

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Study Start: 2011-06-06
• Study Completion: 2014-06-25
• Last Update Posted: 13 January 2020

Recruitment & Eligibility

• Status: Completed
• Sex: All
• Target Recruitment: 48397

Inclusion Criteria

Hold hospital cover with Bupa Australia (and have done so for at least 12 months continuously immediately prior to recruitment);

Have claims evidence of diagnosis of low back pain, diabetes, coronary artery disease, congestive heart failure, or chronic obstructive pulmonary disease;

Are the highest risk member of their household based on predicted risk; and

Have claims-based predicted risk level above a pre-determined threshold of 0.061. This is equivalent to a predicted cost for the following 12 months of $3,050 or more.

Exclusion Criteria

Any individual who shares a household with a previously assigned study subject;

Individuals targeted by Bupa Health Dialog for similar services prior to study initiation (the COACH program for cardiovascular disease, the Genesis Heart Care program for quality improvement, and the Medibank Health Solutions Psychiatric Program);

Individuals involved in other potentially related chronic disease management programs through Bupa Australia prior to study initiation

Individuals with claims evidence prior to study initiation of: End Stage Renal Disease, AIDS, Haemophilia, Necrotizing fasciitis, organ transplant

Study & Design

• Study Type: Interventional
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
The primary outcome measure is the total (non-maternity) cost for health fund members. Cost in this study is measured from the perspective of a private health insurer. That being, the total benefit paid calculated as the summation of hospital, medical (excluding Medicare component) and prostheses. Ancillary benefits will not be included as the role of the intervention in impacting on a range of benefits including dental and optical is not sufficiently well defined.[Monthly until paid claims have accrued for a full 12 month period after he or she is randomized into intervention and control.]

Secondary Outcome Measures

Name	Time	Method
Rates of inpatient (non-maternity) hospitalisations in total in the intervention year. Outcome is assessed based on data linkage to private insurance claims.[12 months after he or she is randomized into intervention and control.];Same day non- maternity admission rates in the intervention year. Outcome is assessed based on data linkage to private insurance claims.[12 months after he or she is randomized into intervention and control.];Rates of non-maternity inpatient bed days in the intervention year. Outcome is assessed based on data linkage to private insurance claims.[12 months after he or she is randomized into intervention and control];Costs (non-maternity) per member in the intervention year by type of service.[Monthly until paid claims have accrued for a full 12 month period after he or she is randomized into intervention and control.]